[go: up one dir, main page]

BRPI0411436A - composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado - Google Patents

composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado

Info

Publication number
BRPI0411436A
BRPI0411436A BRPI0411436-1A BRPI0411436A BRPI0411436A BR PI0411436 A BRPI0411436 A BR PI0411436A BR PI0411436 A BRPI0411436 A BR PI0411436A BR PI0411436 A BRPI0411436 A BR PI0411436A
Authority
BR
Brazil
Prior art keywords
liver
composition
treatment
cirrhosis
dietary supplement
Prior art date
Application number
BRPI0411436-1A
Other languages
English (en)
Inventor
Can V Bui
Cuong Q Bui
Original Assignee
Can V Bui
Cuong Q Bui
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Can V Bui, Cuong Q Bui filed Critical Can V Bui
Publication of BRPI0411436A publication Critical patent/BRPI0411436A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçãO, SUPLEMENTO DIETéTICO, COMPOSIçãO FARMACêUTICA, E, MéTODOS DE TRATAMENTO PARA CáNCER DE FìGADO, PARA DANOS AO FìGADO CAUSADOS POR QUIMIOEMBOLIZAçãO, E DE UM DISTúRBIO DO SISTEMA HEPATOBILIAR, E PARA CIRROSE E HEPATITE DO FìGADO". Uma composição que compreende ingredientes para dieta à base de vegetais/ervas ou extratos, que contém vitaminas e nutrientes que fornece um novo tratamento não tóxico para cânceres do fígado, hepatite e cirrose do fígado. A composição pode ser ingerida como um suplemento diário para dieta para melhorar as funções fisiológicas normais do corpo. A dita composição, ou extratos da mesma, são úteis e eficazes no tratamento e na prevenção de câncer de fígado e possivelmente de outros cânceres. As composições também são úteis para administração a pacientes com hepatite e/ou cirrose do fígado pré-existentes. As composições ou extratos das mesmas podem ser úteis para tratamento de outros cânceres e de outros distúrbios, doenças ou estados de saúde.
BRPI0411436-1A 2003-06-13 2004-06-10 composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado BRPI0411436A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47821603P 2003-06-13 2003-06-13
PCT/US2004/018380 WO2004112483A1 (en) 2003-06-13 2004-06-10 Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver

Publications (1)

Publication Number Publication Date
BRPI0411436A true BRPI0411436A (pt) 2006-07-18

Family

ID=33539077

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411436-1A BRPI0411436A (pt) 2003-06-13 2004-06-10 composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado

Country Status (5)

Country Link
US (2) US8012510B2 (pt)
CN (1) CN1822768A (pt)
BR (1) BRPI0411436A (pt)
CA (1) CA2528288C (pt)
WO (1) WO2004112483A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2528288C (en) 2003-06-13 2018-07-24 Can V. Bui Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver
GB0611130D0 (en) * 2006-06-06 2006-07-19 Alhaj Rasha Cancer treatment
WO2010052680A2 (en) * 2008-11-07 2010-05-14 S.S. Arbel Holdings (1992) Ltd Composition for treatment of cancer
US20130129680A1 (en) * 2011-11-23 2013-05-23 Thomas Christian Lines Method for treating hepatitis c virus infection using quercetin-containing compositions
CN108126134B (zh) * 2018-03-01 2020-10-30 河南中医药大学 一种治疗肝损伤的中药复方组合物、制备方法及其应用
JP7489271B2 (ja) 2020-09-04 2024-05-23 花王株式会社 脂肪線維化抑制剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227279A (ja) * 1983-06-07 1984-12-20 Kunisaku Iwai 健康飲料水
CN1127124A (zh) * 1995-09-28 1996-07-24 李雁北 一种治疗和预防肝病的中药制剂及其制备方法
JP4428740B2 (ja) * 1998-09-14 2010-03-10 株式会社ロッテ ビフィズス菌増殖促進剤
US6299925B1 (en) 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
JP2001299305A (ja) * 2000-04-19 2001-10-30 Bizen Kasei Kk 活性酸素消去用組成物およびその製造法
EP1296696B1 (en) * 2000-06-19 2007-02-28 Skopichenko Dettwiler, Victoria Herbal composition containing calendula and eucalyptus for the treatment and curing of diseases
CA2528288C (en) 2003-06-13 2018-07-24 Can V. Bui Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver

Also Published As

Publication number Publication date
US20080213386A1 (en) 2008-09-04
CA2528288C (en) 2018-07-24
CA2528288A1 (en) 2004-12-29
US8012510B2 (en) 2011-09-06
US20120034310A1 (en) 2012-02-09
WO2004112483A1 (en) 2004-12-29
US8202545B2 (en) 2012-06-19
CN1822768A (zh) 2006-08-23

Similar Documents

Publication Publication Date Title
US6224871B1 (en) Dietary supplement for nutritionally promoting healthy joint function
US6555141B1 (en) L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
RU2010105123A (ru) Композиции для ухода за полостью рта, продукты и способы применения
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
BR0112685A (pt) Composição nutricional
BR9711054A (pt) Composições de carbohidratos de plantas como suplementos dietéticos.
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
Ross Echinacea purpurea: A Proprietary Extract of: Echinacea purpurea: Is Shown to be Safe and Effective in the Prevention of the Common Cold
TW201402129A (zh) 包含蘿蔔硫素之組成物或包含一種蘿蔔硫素前驅物及一種奶薊萃取物或奶薊粉末之組成物
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
Neena et al. An ancient herb aloevera in dentistry: A review
HUP0102489A2 (hu) Biokémiai anyagok alkalmazása emberi test szerveiben található simaizomsejtek összehúzódása okozta egészségi állapotok megelőzésére és kezelésére alkalmas készítményekben
KR970061244A (ko) 치매 치료용 약학 조성물
US7563779B2 (en) L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
IT1295408B1 (it) Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
JP2007501846A5 (pt)
Abraham et al. Management of psoriasis-ayurveda and allopathy-A review
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
JP5118863B2 (ja) 催眠用医薬組成物
IT1314199B1 (it) Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
CN106177925A (zh) 一种蜂王浆美容保健品
US20030072823A1 (en) Immunity enhancing supplements for lung support

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A01N 65/00 , A61K 35/78

Ipc: A61K 36/31 (2006.01), A61K 36/23 (2006.01), A61K 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24, 8O C/C 13, 10 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.